Nuffield Health
437 capabilities
Verified Sep 2026
One of 2,380 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Pathology Department, Nuffield Warwickshire Hospital, The Chase, Leamington Spa
Leamington Spa CV32 6RW , United Kingdom
Leamington Spa CV32 6RW , United Kingdom
Accreditation
Active
UKAS
9338
nuffieldhealth.com
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
9338
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDF
Test Capabilities (437)
| Standard Reference | Description | Category |
|---|---|---|
| HUMAN BODY SAMPLES | BC4.05 using the Roche | HUMAN BODY SAMPLES | BC4.05 using the Roche | Clinical Chemistry |
| HUMAN BODY SAMPLES | BC4.10 using the Roche e411 | HUMAN BODY SAMPLES | BC4.10 using the Roche e411 | Clinical Chemistry |
| HUMAN BODY SAMPLES | Microalbumin: Creatine Ratio By Calculation | HUMAN BODY SAMPLES | Microalbumin: Creatine Ratio By Calculation | Clinical Chemistry |
| HUMAN BODY SAMPLES | Protein: Creatinine Ratio | HUMAN BODY SAMPLES | Protein: Creatinine Ratio | Clinical Chemistry |
| HUMAN BODY SAMPLES | SOP PATH BC4.08 SOP PATH F2 | HUMAN BODY SAMPLES | SOP PATH BC4.08 SOP PATH F2 | Clinical Chemistry |
| HUMAN BODY SAMPLES | SOP PATH F2 BC 4.03, PATH F2 | HUMAN BODY SAMPLES | SOP PATH F2 BC 4.03, PATH F2 | Clinical Chemistry |
| HUMAN BODY SAMPLES | SOP PATH F2 BC3.51 using the | HUMAN BODY SAMPLES | SOP PATH F2 BC3.51 using the | Clinical Chemistry |
| Plasma / serum | B12 | Plasma / serum | B12 | Clinical Chemistry |
| Plasma / serum | BC4.10 using the Roche e411 | Plasma / serum | BC4.10 using the Roche e411 | Clinical Chemistry |
| Plasma / serum | Ferritin | Plasma / serum | Ferritin | Clinical Chemistry |
| Plasma / serum | Folate | Plasma / serum | Folate | Clinical Chemistry |
| Plasma / serum | LDH | Plasma / serum | LDH | Clinical Chemistry |
| Plasma / serum | SOP PATH BC4.08 SOP PATH F2 | Plasma / serum | SOP PATH BC4.08 SOP PATH F2 | Clinical Chemistry |
| Plasma | Turbidimetric Immunoassay | Plasma | Turbidimetric Immunoassay | Clinical Chemistry |
| Serum | (TIBC) SOP PH-LAB-CHEM-13 | Serum | (TIBC) SOP PH-LAB-CHEM-13 | Clinical Chemistry |
| Serum | 24hr Urine Excretion | Serum | 24hr Urine Excretion | Clinical Chemistry |
| Serum | AKI | Serum | AKI | Clinical Chemistry |
| Serum | ALT | Serum | ALT | Clinical Chemistry |
| Serum | ALT, BC4.05 using the Roche | Serum | ALT, BC4.05 using the Roche | Clinical Chemistry |
| Serum | AST:ALT ratio | Serum | AST | Clinical Chemistry |
| Serum | Alanine transaminase | Serum | Alanine transaminase | Clinical Chemistry |
| Serum | Albumin | Serum | Albumin | Clinical Chemistry |
| Serum | Albumin, SOP PATH F2 BC 4.03, PATH F2 | Serum | Albumin, SOP PATH F2 BC 4.03, PATH F2 | Clinical Chemistry |
| Serum | Alkaline Phosphatase | Serum | Alkaline Phosphatase | Clinical Chemistry |
| Serum | Alpha-1-Antitrypsin | Serum | Alpha-1-Antitrypsin | Clinical Chemistry |
| Serum | Amylase | Serum | Amylase | Clinical Chemistry |
| Serum | Aspartate Aminotransferase | Serum | Aspartate Aminotransferase | Clinical Chemistry |
| Serum | B12 Chemiluminescence | Serum | B12 Chemiluminescence | Clinical Chemistry |
| Serum | Bun/Urea | Serum | Bun/Urea | Clinical Chemistry |
| Serum | CA 125 | Serum | CA 125 | Clinical Chemistry |
| Serum | CA153 | Serum | CA153 | Clinical Chemistry |
| Serum | CA19-9 | Serum | CA19-9 | Clinical Chemistry |
| Serum | CA199 | Serum | CA199 | Clinical Chemistry |
| Serum | CPK | Serum | CPK | Clinical Chemistry |
| Serum | CRP OrthoVitros 5600 | Serum | CRP OrthoVitros 5600 | Clinical Chemistry |
| Serum | Calcium | Serum | Calcium | Clinical Chemistry |
| Serum | Chemilluminescence. | Serum | Chemilluminescence. | Clinical Chemistry |
| Serum | Cholesterol, Total | Serum | Cholesterol, Total | Clinical Chemistry |
| Serum | Cholesterol: HDL ratio | Serum | Cholesterol | Clinical Chemistry |
| Serum | Cortisol | Serum | Cortisol | Clinical Chemistry |
| Serum | Creatine Kinase | Serum | Creatine Kinase | Clinical Chemistry |
| Serum | Creatinine | Serum | Creatinine | Clinical Chemistry |
| Serum | Determination of SOP PATH F2 BC3.51 using the | Serum | Determination of SOP PATH F2 BC3.51 using the | Clinical Chemistry |
| Serum | Dry Slide Technology | Serum | Dry Slide Technology | Clinical Chemistry |
| Serum | EGFR | Serum | EGFR | Clinical Chemistry |
| Serum | FT3 & FT4 | Serum | FT3 & FT4 | Clinical Chemistry |
| Serum | Ferritin | Serum | Ferritin | Clinical Chemistry |
| Serum | Ferritin Chemiluminescence | Serum | Ferritin Chemiluminescence | Clinical Chemistry |
| Serum | Folate Immunoassay | Serum | Folate Immunoassay | Clinical Chemistry |
| Serum | GGT | Serum | GGT | Clinical Chemistry |
| Serum | Gamma GT | Serum | Gamma GT | Clinical Chemistry |
| Serum | Gentamicin | Serum | Gentamicin | Clinical Chemistry |
| Serum | Globulins | Serum | Globulins | Clinical Chemistry |
| Serum | Glucose | Serum | Glucose | Clinical Chemistry |
| Serum | Glucose SOP PATH F2 BC 4.03, PATH F2 | Serum | Glucose SOP PATH F2 BC 4.03, PATH F2 | Clinical Chemistry |
| Serum | HDL | Serum | HDL | Clinical Chemistry |
| Serum | HDL Cholesterol | Serum | HDL Cholesterol | Clinical Chemistry |
| Serum | High Density Lipoprotein | Serum | High Density Lipoprotein | Clinical Chemistry |
| Serum | Iron | Serum | Iron | Clinical Chemistry |
| Serum | LDH | Serum | LDH | Clinical Chemistry |
| Serum | LDL cholesterol | Serum | LDL Cholesterol | Clinical Chemistry |
| Serum | Magnesium | Serum | Magnesium | Clinical Chemistry |
| Serum | NT-proBNP Ortho VITROS XT 7600 | Serum | NT-proBNP Ortho VITROS XT 7600 | Clinical Chemistry |
| Serum | Non-HDL Cholestorol | Serum | Non-HDL Cholestorol | Clinical Chemistry |
| Serum | Non-HDL cholesterol | Serum | Non-HDL cholesterol | Clinical Chemistry |
| Serum | Nuffield Health | Serum | Nuffield Health | Clinical Chemistry |
| Serum | ORTHO VITROS XT 7600 | Serum | ORTHO VITROS XT 7600 | Clinical Chemistry |
| Serum | Oestrodiol | Serum | Oestrodiol | Clinical Chemistry |
| Serum | OrthoVitros 5600 | Serum | OrthoVitros 5600 | Clinical Chemistry |
| Serum | PA-PATH-BC-SOP-23 | Serum | PA-PATH-BC-SOP-23 | Clinical Chemistry |
| Serum | PA-PATH-BC-SOP-6 | Serum | PA-PATH-BC-SOP-6 | Clinical Chemistry |
| Serum | Phosphate | Serum | Phosphate | Clinical Chemistry |
| Serum | Potassium | Serum | Potassium | Clinical Chemistry |
| Serum | Potentiometric method | Serum | Potentiometric method | Clinical Chemistry |
| Serum | SOP PH-LAB-CHEM-13 | Serum | SOP PH-LAB-CHEM-13 | Clinical Chemistry |
| Serum | Serum Folate | Serum | Serum Folate | Clinical Chemistry |
| Serum | Sodium | Serum | Sodium | Clinical Chemistry |
| Serum | TH PATH BC SOP 23 | Serum | TH PATH BC SOP 23 | Clinical Chemistry |
| Serum | TSH | Serum | TSH | Clinical Chemistry |
| Serum | Total Bilirubin | Serum | Total Bilirubin | Clinical Chemistry |
| Serum | Total Protein | Serum | Total Protein | Clinical Chemistry |
| Serum | Transferrin | Serum | Transferrin | Clinical Chemistry |
| Serum | Triglyceride | Serum | Triglyceride | Clinical Chemistry |
| Serum | Triglycerides | Serum | Triglycerides | Clinical Chemistry |
| Serum | Troponin I | Serum | Troponin I | Clinical Chemistry |
| Serum | UIBC | Serum | UIBC | Clinical Chemistry |
| Serum | Urea | Serum | Urea | Clinical Chemistry |
| Serum | Uric Acid | Serum | Uric Acid | Clinical Chemistry |
| Serum | Vitamin B12 | Serum | Vitamin B12 | Clinical Chemistry |
| Serum | Vitamin D Immunoassay | Serum | Vitamin D Immunoassay | Clinical Chemistry |
| Serum/Urine | Amylase SOP PATH F2 BC 4.03, PATH F2 | Serum/Urine | Amylase SOP PATH F2 BC 4.03, PATH F2 | Clinical Chemistry |
| Serum/Urine | Calcium BC4.05 using the Roche | Serum/Urine | Calcium BC4.05 using the Roche | Clinical Chemistry |
| Serum/Urine | Inorganic Phosphate | Serum/Urine | Inorganic Phosphate | Clinical Chemistry |
| Serum/Urine | Urea | Serum/Urine | Urea | Clinical Chemistry |
| Serum/Urine | Uric acid | Serum/Urine | Uric acid | Clinical Chemistry |
| Urine | Amylase:creatinine ratio | Urine | Amylase | Clinical Chemistry |
| Urine | BC4.05 | Urine | BC4.05 | Clinical Chemistry |
| Urine | Calcium:creatinine ratio By calculation | Urine | Calcium | Clinical Chemistry |
| Urine | Glucose | Urine | Glucose | Clinical Chemistry |
| Urine | Magnesium:creatinine ratio By calculation | Urine | Magnesium | Clinical Chemistry |
| Urine | Microalbumin BC4.05 using the Roche | Urine | Microalbumin BC4.05 using the Roche | Clinical Chemistry |
| Urine | Nuffield Health | Urine | Nuffield Health | Clinical Chemistry |
| Urine | Phosphate:creatinine ratio By calculation | Urine | Phosphate | Clinical Chemistry |
| Urine | Protein:creatinine ratio | Urine | Protein | Clinical Chemistry |
| Urine | SOP PATH F2 BC 4.03, PATH F2 | Urine | SOP PATH F2 BC 4.03, PATH F2 | Clinical Chemistry |
| Urine | Uric Acid | Urine | Uric Acid | Clinical Chemistry |
| Bacterial & fungal isolates | PATH F2 MB5.93. | Bacterial & fungal isolates | PATH F2 MB5.93. | Clinical Microbiology |
| Bacterial & fungal isolates | WA-PATH F2 MB3.05 | Bacterial & fungal isolates | WA-PATH F2 MB3.05 | Clinical Microbiology |
| Bacterial & fungi isolates | MB5.93 | Bacterial & fungi isolates | MB5.93 | Clinical Microbiology |
| Bacterial & fungi isolates | PATH F2 MB3.39 Sensitivity | Bacterial & fungi isolates | PATH F2 MB3.39 Sensitivity | Clinical Microbiology |
| Bacterial & yeast isolates | Detection of Staphylococcus WA-PATH F2 MB 3.97Staph Latex | Bacterial & yeast isolates | Detection of Staphylococcus WA-PATH F2 MB 3.97Staph Latex | Clinical Microbiology |
| Bacterial & yeast isolates | Identification of ß-haemolytic WA-PATH F2 MB 3.30 | Bacterial & yeast isolates | Identification of ß-haemolytic WA-PATH F2 MB 3.30 | Clinical Microbiology |
| Cellular and fluid material | Staphylococcus aureus 23 | Cellular and fluid material | Staphylococcus aureus 23 | Clinical Microbiology |
| Clear adhesive tape slide | Detection of Enterobius SOP WA-PATH F2 MB 3.81- Ova | Clear adhesive tape slide | Detection of Enterobius SOP WA-PATH F2 MB 3.81- Ova | Clinical Microbiology |
| Faeces | C. difficile GDH Antigen SOP WA-PATH F2 MB 3.43 | Faeces | C. difficile GDH Antigen SOP WA-PATH F2 MB 3.43 | Clinical Microbiology |
| Faeces | Detection of Cryptosporidium SOP WA-PATH F2 MB 3.81- Ova | Faeces | Detection of Cryptosporidium SOP WA-PATH F2 MB 3.81- Ova | Clinical Microbiology |
| Faeces | Detection of ova, cysts & SOP WA-PATH F2 MB 3.81- Ova | Faeces | Detection of ova, cysts & SOP WA-PATH F2 MB 3.81- Ova | Clinical Microbiology |
| Faeces | Immunochromatographic | Faeces | Immunochromatographic | Clinical Microbiology |
| Faeces | Neelsen stain | Faeces | Neelsen stain | Clinical Microbiology |
| Faeces | Nuffield Health | Faeces | Nuffield Health | Clinical Microbiology |
| Faeces | SOP-WA PATH F2 MB3.92 | Faeces | SOP-WA PATH F2 MB3.92 | Clinical Microbiology |
| Faeces | WA-PATH F2 MB 3.37 – Cold Ziehl | Faeces | WA-PATH F2 MB 3.37 – Cold Ziehl | Clinical Microbiology |
| Joint Fluids | MB 3.74 | Joint Fluids | MB 3.74 | Clinical Microbiology |
| Skin, hair, nails | Isolation of clinically significant SOP WA-PATH F2 MB 3.71 | Skin, hair, nails | Isolation of clinically significant SOP WA-PATH F2 MB 3.71 | Clinical Microbiology |
| Urine | Microscopy and culture | Urine | Microscopy and culture | Clinical Microbiology |
| 9338 | Blood Transfusion activities for In house documented procedures | 9338 | Blood Transfusion activities for In house documented procedures | Hematology |
| Anticoagulated venous blood | BIORAD IH500 and using BIORAD | Anticoagulated venous blood | BIORAD IH500 and using BIORAD | Hematology |
| Anticoagulated venous blood | PA-PATH-BT-SOP-119 | Anticoagulated venous blood | PA-PATH-BT-SOP-119 | Hematology |
| Anticoagulated venous blood | PA-PATH-BT-SOP-123 | Anticoagulated venous blood | PA-PATH-BT-SOP-123 | Hematology |
| Anticoagulated venous blood, | AB Rh D Positive PATH BT SOP 119 | Anticoagulated venous blood, | AB Rh D Positive PATH BT SOP 119 | Hematology |
| Anticoagulated venous blood, | AB Rh D Positive PATH BT SOP 123 | Anticoagulated venous blood, | AB Rh D Positive PATH BT SOP 123 | Hematology |
| Anticoagulated venous blood, | Blood Group by detection and Bio-Rad IH-500 analyser using | Anticoagulated venous blood, | Blood Group by detection and Bio-Rad IH-500 analyser using | Hematology |
| Blood | ABO Procedures using IH-500 | Blood | ABO Procedures using IH-500 | Hematology |
| Blood | ABO Use of the IH- 500 Analyser | Blood | ABO Use of the IH- 500 Analyser | Hematology |
| Blood | APTT PATH F2 HA4.10 | Blood | APTT PATH F2 HA4.10 | Hematology |
| Blood | Anti-A1 SOP PATH F2 BT SOP 1233. 51 | Blood | Anti-A1 SOP PATH F2 BT SOP 1233. 51 | Hematology |
| Blood | Anti-A1 centrifuge | Blood | Anti-A1 centrifuge | Hematology |
| Blood | Anti-B | Blood | Anti-B | Hematology |
| Blood | Anti-C,Cw,c,D,Ee and manufacturer's 11 cell panel | Blood | Anti-C,Cw,c,D,Ee and manufacturer's 11 cell panel | Hematology |
| Blood | Anti-K, k(cellano) SOP PATH F2 BT3. 51 | Blood | Anti-K, k(cellano) SOP PATH F2 BT3. 51 | Hematology |
| Blood | Anti-P1 | Blood | Anti-P1 | Hematology |
| Blood | Antibody confirmation: Manual Blood Transfusion | Blood | Antibody confirmation: Manual Blood Transfusion | Hematology |
| Blood | Antibody titration: SOP PATH F2 BT SOP 1193.39 | Blood | Antibody titration: SOP PATH F2 BT SOP 1193.39 | Hematology |
| Blood | Assessment for cell typing and Manual SOP – WA-PATH F2 HA | Blood | Assessment for cell typing and Manual SOP – WA-PATH F2 HA | Hematology |
| Blood | Assessment for cell typing and SOP WA PATH F2 HA3.35 | Blood | Assessment for cell typing and SOP WA PATH F2 HA3.35 | Hematology |
| Blood | Coagulometer | Blood | Coagulometer | Hematology |
| Blood | Detection of HbA1c SOP WA PATH F2 BC3.14 HbA1C | Blood | Detection of HbA1c SOP WA PATH F2 BC3.14 HbA1C | Hematology |
| Blood | Electrophoresis | Blood | Electrophoresis | Hematology |
| Blood | Lewis System | Blood | Lewis System | Hematology |
| Blood | Lutheran System | Blood | Lutheran System | Hematology |
| Blood | Manual SOP – CH_PATH SOP 29 | Blood | Manual SOP – CH_PATH SOP 29 | Hematology |
| Blood | Manual SOP – GU-PATH F2 HA | Blood | Manual SOP – GU-PATH F2 HA | Hematology |
| Blood | Manual SOP – SO_PATH F2 | Blood | Manual SOP – SO_PATH F2 | Hematology |
| Blood | Manual SOP –NT_PATH F2 | Blood | Manual SOP –NT_PATH F2 | Hematology |
| Blood | Nuffield Health | Blood | Nuffield Health | Hematology |
| Blood | Operation of the Sysmex CA50 | Blood | Operation of the Sysmex CA50 | Hematology |
| Blood | P System | Blood | P System | Hematology |
| Blood | PT Sysmex CA50 Coagulometer | Blood | PT Sysmex CA50 Coagulometer | Hematology |
| Blood | Rate (ESR) | Blood | Rate (ESR) | Hematology |
| Blood | Rhesus-Rh Using manufacturer's 11 cell panel | Blood | Rhesus-Rh Using manufacturer's 11 cell panel | Hematology |
| Blood | SOP WA PATH F2 HA3.38 | Blood | SOP WA PATH F2 HA3.38 | Hematology |
| Blood | Sedimentation (mm/hr) PATH-HA-SOP-33 | Blood | Sedimentation (mm/hr) PATH-HA-SOP-33 | Hematology |
| Blood | Sedimentation (mm/hr) SOP WA-PATH F2HA SOP 33 | Blood | Sedimentation (mm/hr) SOP WA-PATH F2HA SOP 33 | Hematology |
| Blood | Using manufacturer's 3 cell panel | Blood | Using manufacturer's 3 cell panel | Hematology |
| Blood | WA-PATH F2 MB3.04 | Blood | WA-PATH F2 MB3.04 | Hematology |
| Blood, serum | TH PATH HA SOP 61 | Blood, serum | TH PATH HA SOP 61 | Hematology |
| EDTA anticoagulated whole | BASO Sysmex XN-550 | EDTA anticoagulated whole | BASO Sysmex XN-550 | Hematology |
| EDTA anticoagulated whole | BASO Sysmex XN1000 | EDTA anticoagulated whole | BASO Sysmex XN1000 | Hematology |
| EDTA anticoagulated whole | EOS Sysmex XN-550 | EDTA anticoagulated whole | EOS Sysmex XN-550 | Hematology |
| EDTA anticoagulated whole | EOS Sysmex XN1000 | EDTA anticoagulated whole | EOS Sysmex XN1000 | Hematology |
| EDTA anticoagulated whole | EX-PATH F2.1 HA3.1 | EDTA anticoagulated whole | EX-PATH F2.1 HA3.1 | Hematology |
| EDTA anticoagulated whole | Erythrocyte Sedimentation Vescube 30 Touch Modified | EDTA anticoagulated whole | Erythrocyte Sedimentation Vescube 30 Touch Modified | Hematology |
| EDTA anticoagulated whole | HCT Sysmex XN-550 | EDTA anticoagulated whole | HCT Sysmex XN-550 | Hematology |
| EDTA anticoagulated whole | HCT Sysmex XN1000 | EDTA anticoagulated whole | HCT Sysmex XN1000 | Hematology |
| EDTA anticoagulated whole | HGB Sysmex XN-550 | EDTA anticoagulated whole | HGB Sysmex XN-550 | Hematology |
| EDTA anticoagulated whole | HGB Sysmex XN1000 | EDTA anticoagulated whole | HGB Sysmex XN1000 | Hematology |
| EDTA anticoagulated whole | LYMPH Sysmex XN-550 | EDTA anticoagulated whole | LYMPH Sysmex XN-550 | Hematology |
| EDTA anticoagulated whole | LYMPH Sysmex XN1000 | EDTA anticoagulated whole | LYMPH Sysmex XN1000 | Hematology |
| EDTA anticoagulated whole | MCH Sysmex XN-550 | EDTA anticoagulated whole | MCH Sysmex XN-550 | Hematology |
| EDTA anticoagulated whole | MCH Sysmex XN1000 | EDTA anticoagulated whole | MCH Sysmex XN1000 | Hematology |
| EDTA anticoagulated whole | MCHC Sysmex XN-550 | EDTA anticoagulated whole | MCHC Sysmex XN-550 | Hematology |
| EDTA anticoagulated whole | MCHC Sysmex XN1000 | EDTA anticoagulated whole | MCHC Sysmex XN1000 | Hematology |
| EDTA anticoagulated whole | MCV Sysmex XN-550 | EDTA anticoagulated whole | MCV Sysmex XN-550 | Hematology |
| EDTA anticoagulated whole | MCV Sysmex XN1000 | EDTA anticoagulated whole | MCV Sysmex XN1000 | Hematology |
| EDTA anticoagulated whole | MONO Sysmex XN-550 | EDTA anticoagulated whole | MONO Sysmex XN-550 | Hematology |
| EDTA anticoagulated whole | MONO Sysmex XN1000 | EDTA anticoagulated whole | MONO Sysmex XN1000 | Hematology |
| EDTA anticoagulated whole | NEUT Sysmex XN-550 | EDTA anticoagulated whole | NEUT Sysmex XN-550 | Hematology |
| EDTA anticoagulated whole | NEUT Sysmex XN1000 | EDTA anticoagulated whole | NEUT Sysmex XN1000 | Hematology |
| EDTA anticoagulated whole | PA PATH HA SOP 5.1 | EDTA anticoagulated whole | PA PATH HA SOP 5.1 | Hematology |
| EDTA anticoagulated whole | PLT Sysmex XN-550 | EDTA anticoagulated whole | PLT Sysmex XN-550 | Hematology |
| EDTA anticoagulated whole | PLT Sysmex XN1000 | EDTA anticoagulated whole | PLT Sysmex XN1000 | Hematology |
| EDTA anticoagulated whole | RBC Sysmex XN-550 | EDTA anticoagulated whole | RBC Sysmex XN-550 | Hematology |
| EDTA anticoagulated whole | RBC Sysmex XN1000 | EDTA anticoagulated whole | RBC Sysmex XN1000 | Hematology |
| EDTA anticoagulated whole | RDW-CV Sysmex XN-550 | EDTA anticoagulated whole | RDW-CV Sysmex XN-550 | Hematology |
| EDTA anticoagulated whole | RDW-CV Sysmex XN1000 | EDTA anticoagulated whole | RDW-CV Sysmex XN1000 | Hematology |
| EDTA anticoagulated whole | SOP PATH D1.2 POCT 4.04 | EDTA anticoagulated whole | SOP PATH D1.2 POCT 4.04 | Hematology |
| EDTA anticoagulated whole | SOP PATH HA SOP 5 | EDTA anticoagulated whole | SOP PATH HA SOP 5 | Hematology |
| EDTA anticoagulated whole | SOP TH PATH HA SOP 62 | EDTA anticoagulated whole | SOP TH PATH HA SOP 62 | Hematology |
| EDTA anticoagulated whole | Sedimentation (mm/hr) SOP-PA PATH HA SOP 33 | EDTA anticoagulated whole | Sedimentation (mm/hr) SOP-PA PATH HA SOP 33 | Hematology |
| EDTA anticoagulated whole | Sedimentation (mm/hr) TH PATH HA SOP 33 | EDTA anticoagulated whole | Sedimentation (mm/hr) TH PATH HA SOP 33 | Hematology |
| EDTA anticoagulated whole | Spectrophotometry | EDTA anticoagulated whole | Spectrophotometry | Hematology |
| EDTA anticoagulated whole | WBC Sysmex XN-550 | EDTA anticoagulated whole | WBC Sysmex XN-550 | Hematology |
| EDTA anticoagulated whole | WBC Sysmex XN1000 | EDTA anticoagulated whole | WBC Sysmex XN1000 | Hematology |
| Plasma | Compatibility testing: Manual Blood Transfusion | Plasma | Compatibility testing: Manual Blood Transfusion | Hematology |
| Plasma | D-DIMER Sysmex CA660 Coagulometer | Plasma | D-DIMER Sysmex CA660 Coagulometer | Hematology |
| Plasma | D-DIMER Sysmex CS2000i Coagulometer | Plasma | D-DIMER Sysmex CS2000i Coagulometer | Hematology |
| Plasma | Fibrinogen Sysmex CS2000i Coagulometer | Plasma | Fibrinogen Sysmex CS2000i Coagulometer | Hematology |
| Plasma | INR Sysmex CA660 Coagulometer | Plasma | INR Sysmex CA660 Coagulometer | Hematology |
| Plasma | Partial Thromboplastin Time Sysmex CA660 Coagulometer | Plasma | Partial Thromboplastin Time Sysmex CA660 Coagulometer | Hematology |
| Plasma | Partial Thromboplastin Time Sysmex CS2000i Coagulometer | Plasma | Partial Thromboplastin Time Sysmex CS2000i Coagulometer | Hematology |
| Plasma | Prothrombin Time (PT) Sysmex CA660 Coagulometer | Plasma | Prothrombin Time (PT) Sysmex CA660 Coagulometer | Hematology |
| Plasma | Prothrombin Time (PT) Sysmex CS2000i Coagulometer | Plasma | Prothrombin Time (PT) Sysmex CS2000i Coagulometer | Hematology |
| Plasma | SOP PA PATH HA SOP 61 | Plasma | SOP PA PATH HA SOP 61 | Hematology |
| Plasma | SOP TH PATH HA SOP 28 | Plasma | SOP TH PATH HA SOP 28 | Hematology |
| Whole Blood (EDTA) | B Rh D Positive SOP LP-TH-PATH-BT02 | Whole Blood (EDTA) | B Rh D Positive SOP LP-TH-PATH-BT02 | Hematology |
| Whole Blood (EDTA) | HbA1c Ortho VITROS XT 7600 | Whole Blood (EDTA) | HbA1c Ortho VITROS XT 7600 | Hematology |
| Whole Blood (EDTA) | PA PATH BC SOP 23 | Whole Blood (EDTA) | PA PATH BC SOP 23 | Hematology |
| Whole Blood | AB Rh D Positive PATH BT SOP 119 | Whole Blood | AB Rh D Positive PATH BT SOP 119 | Hematology |
| Whole Blood | Anti-C,Cw,c,D,Ee PATH BT SOP 119 | Whole Blood | Anti-C,Cw,c,D,Ee PATH BT SOP 119 | Hematology |
| Whole Blood | Anti-P1 | Whole Blood | Anti-P1 | Hematology |
| Whole Blood | Antibody Screen by detection Bio-Rad IH-500 analyser using | Whole Blood | Antibody Screen by detection Bio-Rad IH-500 analyser using | Hematology |
| Whole Blood | B Rh D Positive PATH BT SOP 123 | Whole Blood | B Rh D Positive PATH BT SOP 123 | Hematology |
| Whole Blood | Blood Group by detection and Bio-Rad IH-500 analyser using | Whole Blood | Blood Group by detection and Bio-Rad IH-500 analyser using | Hematology |
| Whole Blood | Kell System | Whole Blood | Kell System | Hematology |
| Whole Blood | Lewis System | Whole Blood | Lewis System | Hematology |
| Whole Blood | Lutheran System | Whole Blood | Lutheran System | Hematology |
| Whole Blood | P System | Whole Blood | P System | Hematology |
| Whole Blood | PATH BT SOP 119 | Whole Blood | PATH BT SOP 119 | Hematology |
| Whole Blood | Rh- C,c,D,E,e and manufacturer's 3 cell panel | Whole Blood | Rh- C,c,D,E,e and manufacturer's 3 cell panel | Hematology |
| Whole blood | Nuffield Health | Whole blood | Nuffield Health | Hematology |
| Whole blood | Red cell/white cell/platelets PA PATH F2 HA 3.53 | Whole blood | Red cell/white cell/platelets PA PATH F2 HA 3.53 | Hematology |
| Whole blood | SOP PATH F2 HA3.39 | Whole blood | SOP PATH F2 HA3.39 | Hematology |
| Whole blood | TH PATH HA SOP 36 | Whole blood | TH PATH HA SOP 36 | Hematology |
| Whole blood, plasma | Anti-C,Cw,c,D,Ee PATH BT SOP 123 | Whole blood, plasma | Anti-C,Cw,c,D,Ee PATH BT SOP 123 | Hematology |
| Whole blood, plasma | Anti-K PATH BT SOP 119 | Whole blood, plasma | Anti-K PATH BT SOP 119 | Hematology |
| Whole blood, plasma | Antibody Screen by detection Bio-Rad IH-500 and using Bio-Rad | Whole blood, plasma | Antibody Screen by detection Bio-Rad IH-500 and using Bio-Rad | Hematology |
| Whole blood, plasma | PATH BT SOP 123 | Whole blood, plasma | PATH BT SOP 123 | Hematology |
| Air dried slides, fixed slides | Staining for the purposes of SOP WA PATH F2 CY3.07 | Air dried slides, fixed slides | Staining for the purposes of SOP WA PATH F2 CY3.07 | Histopathology / Cytology |
| Blood | (Modified Giemsa) | Blood | (Modified Giemsa) | Histopathology / Cytology |
| Embedded Tissue (FFPE) | A basal epithelial cell P63 | Embedded Tissue (FFPE) | A basal epithelial cell P63 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Activated T and B cells CD31 | Embedded Tissue (FFPE) | Activated T and B cells CD31 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Anaplastic large cell CD34 | Embedded Tissue (FFPE) | Anaplastic large cell CD34 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | B cell activator proteins CD23 | Embedded Tissue (FFPE) | B cell activator proteins CD23 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | B cells and B Cell neoplasms CD99 | Embedded Tissue (FFPE) | B cells and B Cell neoplasms CD99 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | B cells and identification of CD20 | Embedded Tissue (FFPE) | B cells and identification of CD20 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | CD1a positive cells in normal CD1a | Embedded Tissue (FFPE) | CD1a positive cells in normal CD1a | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Classification of B cell Bcl6 | Embedded Tissue (FFPE) | Classification of B cell Bcl6 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Classification of T-Cell CD3 | Embedded Tissue (FFPE) | Classification of T-Cell CD3 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Classification of Will’s tumour, WT1 | Embedded Tissue (FFPE) | Classification of Will’s tumour, WT1 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Classification of melanomas HMB45 | Embedded Tissue (FFPE) | Classification of melanomas HMB45 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Cytokeratin – classification of AE1/AE3 | Embedded Tissue (FFPE) | Cytokeratin – classification of AE1/AE3 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Cytotoxic suppressor T Cells CD8 | Embedded Tissue (FFPE) | Cytotoxic suppressor T Cells CD8 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | D1 HS4.76 Bond-III | Embedded Tissue (FFPE) | D1 HS4.76 Bond-III | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Detection of activated CD68 | Embedded Tissue (FFPE) | Detection of activated CD68 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Differential diagnosis of DOG 1 | Embedded Tissue (FFPE) | Differential diagnosis of DOG 1 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Differentiation between CK5 (CK5/6) | Embedded Tissue (FFPE) | Differentiation between CK5 (CK5/6) | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Epithelial tissues MNF116 | Embedded Tissue (FFPE) | Epithelial tissues MNF116 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Ewing’s sarcoma marker CD117 | Embedded Tissue (FFPE) | Ewing’s sarcoma marker CD117 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | F2 HS3.38 | Embedded Tissue (FFPE) | F2 HS3.38 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Follicular dendritic cells and CD21 | Embedded Tissue (FFPE) | Follicular dendritic cells and CD21 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Follicular lymphoma. Various Bcl2 | Embedded Tissue (FFPE) | Follicular lymphoma. Various Bcl2 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | GCDFP15 | Embedded Tissue (FFPE) | GCDFP15 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Glandular and transitional CK7 | Embedded Tissue (FFPE) | Glandular and transitional CK7 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | HS3.41 | Embedded Tissue (FFPE) | HS3.41 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | HS3.51 | Embedded Tissue (FFPE) | HS3.51 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | HS3.59 | Embedded Tissue (FFPE) | HS3.59 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | HS3.61 | Embedded Tissue (FFPE) | HS3.61 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | HS3.62 | Embedded Tissue (FFPE) | HS3.62 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Hodgkin’s disease CD15 | Embedded Tissue (FFPE) | Hodgkin’s disease CD15 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | ID of B and T cell CD5 | Embedded Tissue (FFPE) | ID of B and T cell CD5 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | ID of Burkitts’ lymphoma, CD10 | Embedded Tissue (FFPE) | ID of Burkitts’ lymphoma, CD10 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Identification of NK cells, CD56 | Embedded Tissue (FFPE) | Identification of NK cells, CD56 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Identification of S100-positive S100 | Embedded Tissue (FFPE) | Identification of S100-positive S100 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Identification of epithelial CK19 | Embedded Tissue (FFPE) | Identification of epithelial CK19 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Identification of epithelial cells BEREP4 | Embedded Tissue (FFPE) | Identification of epithelial cells BEREP4 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Identification of lymphatic D2-40 | Embedded Tissue (FFPE) | Identification of lymphatic D2-40 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Identification of mantle cell CYCLIN D1 | Embedded Tissue (FFPE) | Identification of mantle cell CYCLIN D1 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Identification of p53 in normal P53 | Embedded Tissue (FFPE) | Identification of p53 in normal P53 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Ki-67 expressing neoplastic KI67 | Embedded Tissue (FFPE) | Ki-67 expressing neoplastic KI67 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | MUM1-expressing B cells in, MUM-1 | Embedded Tissue (FFPE) | MUM1-expressing B cells in, MUM-1 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Mononuclear phagocytes CD79A | Embedded Tissue (FFPE) | Mononuclear phagocytes CD79A | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Mucin-like glycoproteins – CA125 | Embedded Tissue (FFPE) | Mucin-like glycoproteins – CA125 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Normal B lymphocytes and CD30 | Embedded Tissue (FFPE) | Normal B lymphocytes and CD30 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Normal and abnormal gastric CK20 | Embedded Tissue (FFPE) | Normal and abnormal gastric CK20 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | PATH F2 HS3.63 | Embedded Tissue (FFPE) | PATH F2 HS3.63 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | PATH F2 HS3.64 | Embedded Tissue (FFPE) | PATH F2 HS3.64 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | PATH-F2 HS3.61 | Embedded Tissue (FFPE) | PATH-F2 HS3.61 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | T Lymphocytes, myeloid CD43 | Embedded Tissue (FFPE) | T Lymphocytes, myeloid CD43 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Terminally differentiated CDX2 | Embedded Tissue (FFPE) | Terminally differentiated CDX2 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Thymocytes and T helper CD4 | Embedded Tissue (FFPE) | Thymocytes and T helper CD4 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Thyroid transcription factor-1 TTF-1 | Embedded Tissue (FFPE) | Thyroid transcription factor-1 TTF-1 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Transmembrane tyrosine CD138 | Embedded Tissue (FFPE) | Transmembrane tyrosine CD138 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Tumour marker – CK18/8 | Embedded Tissue (FFPE) | Tumour marker – CK18/8 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | Tumour suppressor gene P16 | Embedded Tissue (FFPE) | Tumour suppressor gene P16 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | WA-PATH F2 HS3.44 | Embedded Tissue (FFPE) | WA-PATH F2 HS3.44 | Histopathology / Cytology |
| Embedded Tissue (FFPE) | WA-PATH F2 HS3.52 | Embedded Tissue (FFPE) | WA-PATH F2 HS3.52 | Histopathology / Cytology |
| Fixed and fresh tissue, | Examination of tissues in order TU PATH-HS 4.76 | Fixed and fresh tissue, | Examination of tissues in order TU PATH-HS 4.76 | Histopathology / Cytology |
| Fixed and fresh tissue, | F2-HS3.08 and OX-PATH D1 | Fixed and fresh tissue, | F2-HS3.08 and OX-PATH D1 | Histopathology / Cytology |
| Fixed and fresh tissue, | GL-PATH-175 Microtomy Section | Fixed and fresh tissue, | GL-PATH-175 Microtomy Section | Histopathology / Cytology |
| Fixed and fresh tissue, | GL-PATH-HIS-SOP-7 Tissue | Fixed and fresh tissue, | GL-PATH-HIS-SOP-7 Tissue | Histopathology / Cytology |
| Fixed and fresh tissue, | HS3.04 Specimen Cut-up Category | Fixed and fresh tissue, | HS3.04 Specimen Cut-up Category | Histopathology / Cytology |
| Fixed and fresh tissue, | HS4.69 | Fixed and fresh tissue, | HS4.69 | Histopathology / Cytology |
| Fixed and fresh tissue, | Leica ASP300S processor | Fixed and fresh tissue, | Leica ASP300S processor | Histopathology / Cytology |
| Fixed and fresh tissue, | Microtomy Using Leica RM 2235 | Fixed and fresh tissue, | Microtomy Using Leica RM 2235 | Histopathology / Cytology |
| Fixed and fresh tissue, | PATH-188 BMS Specimen | Fixed and fresh tissue, | PATH-188 BMS Specimen | Histopathology / Cytology |
| Fixed and fresh tissue, | XL- SOP OX-PATH F2-HS-3.56 | Fixed and fresh tissue, | XL- SOP OX-PATH F2-HS-3.56 | Histopathology / Cytology |
| Fluids and Fine needle | Cytospin Hologic T2000 | Fluids and Fine needle | Cytospin Hologic T2000 | Histopathology / Cytology |
| Fluids and Fine needle | PATH F2 CY3.24 Systemic | Fluids and Fine needle | PATH F2 CY3.24 Systemic | Histopathology / Cytology |
| Fluids and Fine needle | WA-PATH F2 HS3.24 Non-Gynae | Fluids and Fine needle | WA-PATH F2 HS3.24 Non-Gynae | Histopathology / Cytology |
| Slides prepared in house | WA PATH F2 CY3.10 | Slides prepared in house | WA PATH F2 CY3.10 | Histopathology / Cytology |
| Slides prepared in house | WA-PATH G1 CY 3.26. | Slides prepared in house | WA-PATH G1 CY 3.26. | Histopathology / Cytology |
| Slides prepared in house | WA-PATH-F2 HS3.04 | Slides prepared in house | WA-PATH-F2 HS3.04 | Histopathology / Cytology |
| HUMAN BODY SAMPLES | Electrochemiluminescence | HUMAN BODY SAMPLES | Electrochemiluminescence | Immunology / Serology |
| Plasma / serum | AFP | Plasma / serum | AFP | Immunology / Serology |
| Plasma / serum | C153 | Plasma / serum | C153 | Immunology / Serology |
| Plasma / serum | C199 | Plasma / serum | C199 | Immunology / Serology |
| Plasma / serum | CA125 | Plasma / serum | CA125 | Immunology / Serology |
| Plasma / serum | CEA | Plasma / serum | CEA | Immunology / Serology |
| Plasma / serum | E2 | Plasma / serum | E2 | Immunology / Serology |
| Plasma / serum | FPSA | Plasma / serum | FPSA | Immunology / Serology |
| Plasma / serum | FSH | Plasma / serum | FSH | Immunology / Serology |
| Plasma / serum | FT3 | Plasma / serum | FT3 | Immunology / Serology |
| Plasma / serum | FT4 | Plasma / serum | FT4 | Immunology / Serology |
| Plasma / serum | HCG | Plasma / serum | HCG | Immunology / Serology |
| Plasma / serum | LH | Plasma / serum | LH | Immunology / Serology |
| Plasma / serum | Oestradiol | Plasma / serum | Oestradiol | Immunology / Serology |
| Plasma / serum | PSA | Plasma / serum | PSA | Immunology / Serology |
| Plasma / serum | Progesterone | Plasma / serum | Progesterone | Immunology / Serology |
| Plasma / serum | Prolactin | Plasma / serum | Prolactin | Immunology / Serology |
| Plasma / serum | Roche e411 by immunoassay | Plasma / serum | Roche e411 by immunoassay | Immunology / Serology |
| Plasma / serum | SHBG | Plasma / serum | SHBG | Immunology / Serology |
| Plasma / serum | TSH | Plasma / serum | TSH | Immunology / Serology |
| Plasma / serum | Testosterone | Plasma / serum | Testosterone | Immunology / Serology |
| Serum | AFP | Serum | AFP | Immunology / Serology |
| Serum | Analyser | Serum | Analyser | Immunology / Serology |
| Serum | Anti-CCP | Serum | Anti-CCP | Immunology / Serology |
| Serum | C3 | Serum | C3 | Immunology / Serology |
| Serum | C4 | Serum | C4 | Immunology / Serology |
| Serum | CA 125 | Serum | CA125 | Immunology / Serology |
| Serum | CA 15-3 | Serum | CA15-3 | Immunology / Serology |
| Serum | CA19-9 Electrochemiluminescence | Serum | CA19-9 Electrochemiluminescence | Immunology / Serology |
| Serum | CEA | Serum | CEA | Immunology / Serology |
| Serum | CRP | Serum | CRP | Immunology / Serology |
| Serum | Ceruloplasmin | Serum | Ceruloplasmin | Immunology / Serology |
| Serum | Detection of: Dynex DS2 (ELISA) and manual | Serum | Detection of: bioMérieux VIDAS using ELFA | Immunology / Serology |
| Serum | Drugs | Serum | Drugs | Immunology / Serology |
| Serum | Eggs and Fowl | Serum | Eggs and Fowl | Immunology / Serology |
| Serum | Epidermals and animal | Serum | Epidermals and animal | Immunology / Serology |
| Serum | Estradiol | Serum | Estradiol | Immunology / Serology |
| Serum | FSH | Serum | FSH | Immunology / Serology |
| Serum | FT3 | Serum | FT3 | Immunology / Serology |
| Serum | FT4 | Serum | FT4 | Immunology / Serology |
| Serum | Foods – Miscellaneous | Serum | Foods – Miscellaneous | Immunology / Serology |
| Serum | Grass Pollens of the Phadia 250 Immunology | Serum | Grass Pollens of the Phadia 250 Immunology | Immunology / Serology |
| Serum | HCG | Serum | HCG | Immunology / Serology |
| Serum | HIV I/II Combi | Serum | HIV I/II Combi | Immunology / Serology |
| Serum | Hep B Surface Antibody PATH E2 VR 3.13, WA-PATH E2 | Serum | Hep B Surface Antibody PATH E2 VR 3.13, WA-PATH E2 | Immunology / Serology |
| Serum | Hep B Surface Antigen VR3.1 using Roche Cobas 6000 | Serum | Hep B Surface Antigen VR3.1 using Roche Cobas 6000 | Immunology / Serology |
| Serum | Hep Be antibody | Serum | Hep Be antibody | Immunology / Serology |
| Serum | Hep Be antigen | Serum | Hep Be antigen | Immunology / Serology |
| Serum | Hep C Antibody | Serum | Hep C antibody | Immunology / Serology |
| Serum | IgA | Serum | IgA | Immunology / Serology |
| Serum | IgG | Serum | IgG | Immunology / Serology |
| Serum | IgM | Serum | IgM: EMC-VSP-002 App 5 | Immunology / Serology |
| Serum | Immunoassay | Serum | Immunoassay | Immunology / Serology |
| Serum | LH | Serum | LH | Immunology / Serology |
| Serum | Meat | Serum | Meat | Immunology / Serology |
| Serum | Microorganisms | Serum | Microorganisms | Immunology / Serology |
| Serum | Milk | Serum | Milk | Immunology / Serology |
| Serum | Mites | Serum | Mites | Immunology / Serology |
| Serum | Mixes | Serum | Mixes | Immunology / Serology |
| Serum | PSA | Serum | PSA | Immunology / Serology |
| Serum | PSA Free | Serum | PSA Free | Immunology / Serology |
| Serum | PSA Total | Serum | PSA Total | Immunology / Serology |
| Serum | Progesterone | Serum | Progesterone | Immunology / Serology |
| Serum | Prolactin | Serum | Prolactin | Immunology / Serology |
| Serum | Rheumatoid Factor | Serum | Rheumatoid factor | Immunology / Serology |
| Serum | Rheumatoid Factor (RhF) Ortho Vitros 7600 Microtip Method | Serum | Rheumatoid Factor (RhF) Ortho Vitros 7600 Microtip Method | Immunology / Serology |
| Serum | SHBG | Serum | SHBG | Immunology / Serology |
| Serum | Specific IgE to: SOP PATH D1 IM 4.10 Operation | Serum | Specific IgE to: SOP PATH D1 IM 4.10 Operation | Immunology / Serology |
| Serum | Spices | Serum | Spices | Immunology / Serology |
| Serum | Testosterone | Serum | Testosterone | Immunology / Serology |
| Serum | Total IgE SOP PATH D1 IM 4.10 Operation | Serum | Total IgE SOP PATH D1 IM 4.10 Operation | Immunology / Serology |
| Serum | Tree Pollens | Serum | Tree Pollens | Immunology / Serology |
| Serum | Venoms | Serum | Venoms | Immunology / Serology |
| Serum | Weed Pollens Analyser | Serum | Weed Pollens Analyser | Immunology / Serology |
| Serum | Î’-HCG | Serum | Î’-HCG | Immunology / Serology |
| Urine | Detection of βhCG. SOP SO-PATH F2 HA3.40 using | Urine | Detection of βhCG. SOP SO-PATH F2 HA3.40 using | Immunology / Serology |
| Urine | Kit and immunochromatography | Urine | Kit and immunochromatography | Immunology / Serology |
| Cellular & fluid material | 3.011; 3.013; 3.015 | Cellular & fluid material | 3.011; 3.013; 3.015 | Medical / Clinical Laboratory |
| Plasma / serum | SOP PATH BC SOP 6 | Plasma / serum | SOP PATH BC SOP 6 | Medical / Clinical Laboratory |
| AND FLUIDS | Examination of tissues in order SOP PATH F2 using (Leica | AND FLUIDS | Examination of tissues in order SOP PATH F2 using (Leica | Other |
| Air dried slides, fixed slides | Cell Differentiation CY3.25 Automated staining: | Air dried slides, fixed slides | Cell Differentiation CY3.25 Automated staining: | Other |
| Air dried slides, fixed slides | Staining for the purposes of SOP WA PATH F2 CY3.07 and | Air dried slides, fixed slides | Staining for the purposes of SOP WA PATH F2 CY3.07 and | Other |
| Blood | 3.30-1 | Blood | 3.30-1 | Other |
| Blood | Anti-A Or | Blood | Anti-A Or | Other |
| Blood | Determination of plasma SOP WA- PATH F2 HA4.24 using | Blood | Determination of plasma SOP WA- PATH F2 HA4.24 using | Other |
| Blood | Grunwald) | Blood | Grunwald) | Other |
| Blood | HA3.26 Blood film preparation and | Blood | HA3.26 Blood film preparation and | Other |
| Blood | Kit-RAL 555 staining (May Giemsa | Blood | Kit-RAL 555 staining (May Giemsa | Other |
| Blood | Manufacturer's 3 cell panel with | Blood | Manufacturer's 3 cell panel with | Other |
| Cervical Smear (PreservCyt | Detection of HPV SOP PATH F2 VR4.16 HPV | Cervical Smear (PreservCyt | Detection of HPV SOP PATH F2 VR4.16 HPV | Other |
| Embedded Tissue (FFPE) | SOP: WA-PATH D1 HS4.76 Bond- | Embedded Tissue (FFPE) | SOP: WA-PATH D1 HS4.76 Bond- | Other |
| Faeces | Parasep concentration and | Faeces | Parasep concentration and | Other |
| HUMAN BODY SAMPLES | C6000/C501 Analyser and | HUMAN BODY SAMPLES | C6000/C501 Analyser and | Other |
| HUMAN BODY SAMPLES | Roche C6000/e601 Analyser and | HUMAN BODY SAMPLES | Roche C6000/e601 Analyser and | Other |
| HUMAN BODY SAMPLES | below: | HUMAN BODY SAMPLES | below: | Other |
| Nuffield Health | Nuffield Health | Other |
| Plasma | 61 | Plasma | 61 | Other |
| Plasma | Detection | Plasma | Detection | Other |
| Plasma | Nuffield Health | Plasma | Nuffield Health | Other |
| Plasma | PA PATH HA SOP 61 | Plasma | PA PATH HA SOP 61 | Other |
| Plasma | SOP PATH F2 HA4.01; 02HA SOP | Plasma | SOP PATH F2 HA4.01; 02HA SOP | Other |
| Serum | ALP Roche C311 Analyser and | Serum | ALP Roche C311 Analyser and | Other |
| Serum | ALP, C6000/C501 Analyser and | Serum | ALP, C6000/C501 Analyser and | Other |
| Serum | ALT Roche C311 Analyser and | Serum | ALT Roche C311 Analyser and | Other |
| Serum | AST Roche C311 Analyser and | Serum | AST Roche C311 Analyser and | Other |
| Serum | Amylase Roche C311 Analyser and | Serum | Amylase Roche C311 Analyser and | Other |
| Serum | BC4.05 | Serum | BC4.05 | Other |
| Serum | CA15-3 Roche C6000/e601 Analyser and | Serum | CA15-3 Roche C6000/e601 Analyser and | Other |
| Serum | CRP Roche C311 Analyser and | Serum | CRP Roche C311 Analyser and | Other |
| Serum | Calcium Roche C311 Analyser and | Serum | Calcium Roche C311 Analyser and | Other |
| Serum | Chloride Roche C311 Analyser and | Serum | Chloride Roche C311 Analyser and | Other |
| Serum | Cholesterol Roche C311 Analyser and | Serum | Cholesterol Roche C311 Analyser and | Other |
| Serum | Creatine Kinase (CK) Roche C311 Analyser and | Serum | Creatine Kinase (CK) Roche C311 Analyser and | Other |
| Serum | LDH Roche C311 Analyser and | Serum | LDH Roche C311 Analyser and | Other |
| Serum | Potassium Roche C311 Analyser and | Serum | Potassium Roche C311 Analyser and | Other |
| Serum | SOP PATH F2 BC 4.03, PATH F2 | Serum | SOP PATH F2 BC 4.03, PATH F2 | Other |
| Serum | Total Bilirubin Roche C311 Analyser and | Serum | Total Bilirubin Roche C311 Analyser and | Other |
| Serum | Urate Roche C311 Analyser and | Serum | Urate Roche C311 Analyser and | Other |
| Serum | Urea Roche C311 Analyser and | Serum | Urea Roche C311 Analyser and | Other |
| Serum/Urine | Creatinine C6000/C501 Analyser and | Serum/Urine | Creatinine C6000/C501 Analyser and | Other |
| Slides prepared in house | SOP WA PATH F2 CY3.09 and | Slides prepared in house | SOP WA PATH F2 CY3.09 and | Other |
| Solution) | Nuffield Health | Solution) | Nuffield Health | Other |
| Urine | 8SG Strips (Leucocytes, SOP EXPATH D1.2 POCT 4.08 | Urine | 8SG Strips (Leucocytes, SOP EXPATH D1.2 POCT 4.08 | Other |
| Urine | C6000/C501 Analyser and | Urine | C6000/C501 Analyser and | Other |
| Urine | Roche C311 Analyser and | Urine | Roche C311 Analyser and | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.